FACULTY RESEARCH

Faculty List

Martin Sebastian Allen-Auerbach, M.D.

Work Email Address: mauerbach@mednet.ucla.edu

Work Phone Number: (310) 983-1444

Health System

Work Address:
200 Medical Plaza, Suite B-114
Los Angeles, CA 90095

Department / Division Affiliations
Medical Director, Nuclear Medicine Clinic
Health Sciences Associate Clinical Professor, Molecular & Medical Pharmacology

Research Interests
Ongoing research includes clinical studies that address the role of molecular imaging with PET in the management of patients with lymphoma, breast cancer, colorectal cancer and lung cancer. Of special interest are the fusion of form and function provided by PET/CT allowing for non-invasive insights into malignant disease processes, and monitoring of cancer treatment.


Publications
Karantanis Dimitrios, Allen-Auerbach Martin, Czernin Johannes Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma. Clinical nuclear medicine. 2012; 37(1): 49-53.
Benz Matthias R, Herrmann Ken, Walter Franziska, Garon Edward B, Reckamp Karen L, Figlin Robert, Phelps Michael E, Weber Wolfgang A, Czernin Johannes, Allen-Auerbach Martin S (18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011; 52(11): 1684-9.
Walter Franziska, Czernin Johannes, Hall Theodore, Allen-Auerbach Martin, Walter Martin A, Dunkelmann Simone, Federman Noah Is There a Need for Dedicated Bone Imaging in Addition to 18F-FDG PET/CT Imaging in Pediatric Sarcoma Patients?. Journal of pediatric hematology/oncology. 2011; 37(1): .
Benz Matthias R, Czernin Johannes, Allen-Auerbach Martin S, Dry Sarah M, Sutthiruangwong Piriya, Spick Claudio, Radu Caius, Weber Wolfgang A, Tap William D, Eilber Fritz C 3'-deoxy-3'-[(18) F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: A pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response. Cancer. 2011; 52(11): .
Benz Matthias R, Dry Sarah M, Eilber Fritz C, Allen-Auerbach Martin S, Tap William D, Elashoff David, Phelps Michael E, Czernin Johannes Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010; 51(8): 1174-81.